OMC
65
-3
VIX
69
-2
A
39
-2
CTAS
56
-3
CINF
50
5
JCI
46
2
RIG
40
-3
LEG
32
3
CMA
42
2
CHRW
39
3
SYK
51
-6
AEE
41
4
EL
50
7
HCA
35
-5
CNX
65
-3
CCL
33
2
QCOM
69
-2
WHR
35
3
PSX
34
-6
O
39
2
OMC
65
-3
VIX
69
-2
A
39
-2
CTAS
56
-3
CINF
50
5
JCI
46
2
RIG
40
-3
LEG
32
3
CMA
42
2
CHRW
39
3
SYK
51
-6
AEE
41
4
EL
50
7
HCA
35
-5
CNX
65
-3
CCL
33
2
QCOM
69
-2
WHR
35
3
PSX
34
-6
O
39
2
Financhill
Back

Biogen Quote, Financials, Valuation and Earnings

$50 trade to make today with huge potential!

Click here to access my #1 options strategy for overnight wins starting with $50!
Sell
29

BIIB
Biogen

Last Price:
194.44
Seasonality Move:
8.61%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Biogen Price Quote

$194.44
+3.99 (+2.1%)
(Updated: April 19, 2024 at 6:55 PM ET)

Biogen Key Stats

Sell
29
Biogen (BIIB) is a Sell
Day range:
$189.52 - $192.56
52-week range:
$189.52 - $319.76
Dividend yield:
0%
P/E ratio:
23.90
P/S ratio:
2.81
P/B ratio:
1.87%
Volume:
1.3M
Avg. volume:
1.2M
1-year change:
-35.18%
Market cap:
$27.7B
Revenue:
$9.8B
EPS:
$7.98

How Much Does Biogen Make?

  • How Much Are Biogen's Sales Annually?
    BIIB Revenues are $9.8B
  • How Much Profit Does Biogen's Make A Year?
    BIIB net income is $1.2B

Is Biogen Growing As A Company?

  • What Is Biogen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is -0.06%
  • What Is Biogen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.55%

Biogen Stock Price Performance

  • Did Biogen Stock Go Up Last Month?
    Biogen share price went down by -13.2% last month
  • Did BIIB's Share Price Rise Over The Last Year?
    BIIB share price fell by -35.18% over the past 1 year

What Is Biogen 52-Week High & Low?

  • What Is Biogen’s 52-Week High Share Price?
    Biogen has traded as high as $319.76 over the past 52 weeks
  • What Is Biogen’s 52-Week Low Share Price?
    Biogen has traded as low as $189.52 over the past 52 weeks

Biogen Price To Free Cash Flow

  • Is Biogen Stock Overvalued?
    Biogen is trading at a price to free cash flow ratio of 22.40
  • Is Biogen Stock Undervalued?
    Biogen EV to Free Cash Flow ratio is 27.17
  • What Is Biogen’s Price Earnings Growth Ratio?
    BIIB PEG ratio is 0.00
  • Is Biogen Trading At A Premium To Earnings?
    Biogen EV to EBIT ratio is 21.75

Is It Risky To Buy Biogen?

  • How Much Debt Does Biogen Have?
    Total long term debt quarterly is $6.9B
  • How Much Cash Does Biogen Have?
    Cash and short term investments quarterly total is $1B
  • What Is Biogen’s Book Value Per Share?
    Book value per share is 102.14

Is Biogen Cash Flow Positive?

  • What Is BIIB Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.5B
  • What Is Biogen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $149.3M
  • What Is Biogen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$4.1B

Biogen Return On Invested Capital

  • Is Management Doing A Good Job?
    BIIB return on invested capital is 5.58%
  • What Is Biogen Return On Assets?
    ROA measures how assets are converting to revenues and is 4.49%
  • What Is BIIB Return On Equity?
    ROE is a measure of profitability and is 8.19%

Biogen Earnings Date & Stock Price

  • What Is Biogen's Stock Price Today?
    A single share of BIIB can be purchased today for 190.45
  • What Is Biogen’s Stock Symbol?
    Biogen trades on the S&P500 under the ticker symbol: BIIB
  • When Is Biogen’s Next Earnings Date?
    The next quarterly earnings date for Biogen is scheduled on April 25, 2024
  • When Is BIIB's next ex-dividend date?
    Biogen's next ex-dividend date is June 18, 2020
  • How To Buy Biogen Stock?
    You can buy Biogen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Biogen Competitors

  • Who Are Biogen's Competitors?
    Below is a list of companies who compete with Biogen or are related in some way:
    • AbbVie Inc (ABBV)
    • Amgen Inc (AMGN)
    • Bristol-Myers Squibb Co (BMY)
    • Eli Lilly and Co (LLY)
    • Regeneron Pharmaceuticals Inc (REGN)

Biogen Dividend Yield

Data Unavailable

Biogen Analyst Estimates

YoY Growth Past Surprise
EPS: -54.88% -7.21%
Revenue: -6.2% -3.13%

Analyst Recommendations

Buy Recommendations: 16
Hold Recommendations: 9
Sell Recommendations: 0
Price Target: 291.90
Upside from Last Price: 53.27%

Major Shareholders

  • How many BIIB shares are owned by institutional investors?
    189.2M BIIB shares are owned by institutional investors
  • How many BIIB shares are owned by insiders?
    2.2M BIIB shares are owned by insiders